Mirum Pharmaceuticals SVP Sells Shares to Settle RSU Taxes as Company Posts Strong 2025 Sales
Jolanda Howe, senior vice president and global controller at Mirum Pharmaceuticals, sold 968 shares of common stock on February 2, 2026, in a transaction recorded to satisfy tax withholding tied to restricted stock unit vesting. The company reported preliminary unaudited net product sales of about $520 million for 2025, issued guidance of $630 mill…